Chris Cuffe, the chairman of the $650 million Hearts and Minds Investments, says lifting performance is the best way to lift the share price of the high-profile philanthropic-focused fund after its backers got caught up in the brutal tech rout.
Hearts and Minds Investments, which trades under the ticker HM1, has directed $33.9 million to medical research charities since it listed in 2018. But it’s been a tough 12 months for investors in the listed fund, which has slid 45 per cent, compared to a 5.3 per cent fall in the local market.